Mina Mirzaian

2.3k total citations · 1 hit paper
35 papers, 1.6k citations indexed

About

Mina Mirzaian is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Mina Mirzaian has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Physiology, 12 papers in Molecular Biology and 11 papers in Organic Chemistry. Recurrent topics in Mina Mirzaian's work include Lysosomal Storage Disorders Research (22 papers), Carbohydrate Chemistry and Synthesis (11 papers) and Sphingolipid Metabolism and Signaling (8 papers). Mina Mirzaian is often cited by papers focused on Lysosomal Storage Disorders Research (22 papers), Carbohydrate Chemistry and Synthesis (11 papers) and Sphingolipid Metabolism and Signaling (8 papers). Mina Mirzaian collaborates with scholars based in Netherlands, Germany and United States. Mina Mirzaian's co-authors include Johannes M. F. G. Aerts, Ben J. H. M. Poorthuis, Rolf G. Boot, Herman S. Overkleeft, J.E.M. Groener, Gabor E. Linthorst, Carla E. M. Hollak, María Pía Ferraz, Saskia M. Rombach and Wilma E. Donker‐Koopman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mina Mirzaian

32 papers receiving 1.6k citations

Hit Papers

Elevated globotriaosylsphingosine is a hallmark of Fabry ... 2008 2026 2014 2020 2008 100 200 300 400 500

Peers

Mina Mirzaian
Jan Lukáš Germany
Joan Keutzer United States
Cindy van Roomen Netherlands
Manisha Balwani United States
G. T. N. Besley United Kingdom
Mina Mirzaian
Citations per year, relative to Mina Mirzaian Mina Mirzaian (= 1×) peers J. Ledvinová

Countries citing papers authored by Mina Mirzaian

Since Specialization
Citations

This map shows the geographic impact of Mina Mirzaian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina Mirzaian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina Mirzaian more than expected).

Fields of papers citing papers by Mina Mirzaian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mina Mirzaian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina Mirzaian. The network helps show where Mina Mirzaian may publish in the future.

Co-authorship network of co-authors of Mina Mirzaian

This figure shows the co-authorship network connecting the top 25 collaborators of Mina Mirzaian. A scholar is included among the top collaborators of Mina Mirzaian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mina Mirzaian. Mina Mirzaian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mirzaian, Mina, et al.. (2025). Serum 5-Hydroxyindoleacetic Acid Measurements for the Diagnosis and Follow-up of Carcinoid Syndrome. The Journal of Clinical Endocrinology & Metabolism. 110(12). e3980–e3988.
2.
Broekhuizen, Michelle, Mina Mirzaian, Lenie van Rossem, et al.. (2024). First-trimester maternal tryptophan metabolites, utero-placental (vascular)development and hypertensive disorders of pregnancy: The Rotterdam periconceptional cohort. Placenta. 158. 105–112. 2 indexed citations
4.
Valk, Eline S. van der, Mostafa Mohseni, Anand M. Iyer, et al.. (2024). Long-Term Glucocorticoid Exposure and Incident Cardiovascular Diseases—The Lifelines Cohort. The Journal of Clinical Endocrinology & Metabolism. 109(10). 2520–2529. 5 indexed citations
5.
Mirzaian, Mina, et al.. (2023). Determination of cortisone and cortisol in human scalp hair using an improved LC-MS/MS-based method. Clinical Chemistry and Laboratory Medicine (CCLM). 62(1). 118–127. 16 indexed citations
6.
Hoedt, Sandra den, Simone M. Crivelli, Frank Leijten, et al.. (2021). Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer’s Disease and Control Mice. Frontiers in Aging Neuroscience. 13. 765252–765252. 14 indexed citations
7.
Boer, Daphne E.C., Mina Mirzaian, María Pía Ferraz, et al.. (2020). Human glucocerebrosidase mediates formation of xylosyl-cholesterol by β-xylosidase and transxylosidase reactions. Journal of Lipid Research. 62. 100018–100018. 5 indexed citations
8.
Boer, Daphne E.C., Mina Mirzaian, María Pía Ferraz, et al.. (2020). Glucosylated cholesterol in skin: Synthetic role of extracellular glucocerebrosidase. Clinica Chimica Acta. 510. 707–710. 5 indexed citations
9.
Mirzaian, Mina, C.J. Kuo, Marta Artola, et al.. (2019). Role of μ-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish. Journal of Lipid Research. 60(11). 1851–1867. 26 indexed citations
10.
Mirzaian, Mina, Berend Hooibrink, Roelof Ottenhoff, et al.. (2017). Induction of Sphk1 activity in obese adipose tissue macrophages promotes survival. PLoS ONE. 12(7). e0182075–e0182075. 17 indexed citations
11.
Westerhof, Lotte B., Cornelis H. Hokke, Geri F. Moolenaar, et al.. (2017). Human Alpha Galactosidases Transiently Produced in Nicotiana benthamiana Leaves: New Insights in Substrate Specificities with Relevance for Fabry Disease. Frontiers in Plant Science. 8. 1026–1026. 15 indexed citations
12.
Hughes, Christopher J., Mina Mirzaian, Johannes M. F. G. Aerts, et al.. (2017). Quantitative Proteome Analysis of Mouse Liver Lysosomes Provides Evidence for Mannose 6-phosphate-independent Targeting Mechanisms of Acid Hydrolases in Mucolipidosis II. Molecular & Cellular Proteomics. 16(3). 438–450. 28 indexed citations
13.
Smid, Bouwien E., María Pía Ferraz, Marri Verhoek, et al.. (2016). Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients. Orphanet Journal of Rare Diseases. 11(1). 28–28. 51 indexed citations
14.
Mirzaian, Mina, Patrick Wisse, María Pía Ferraz, et al.. (2016). Accurate quantification of sphingosine-1-phosphate in normal and Fabry disease plasma, cells and tissues by LC-MS/MS with 13 C-encoded natural S1P as internal standard. Clinica Chimica Acta. 459. 36–44. 13 indexed citations
15.
Mirzaian, Mina, Patrick Wisse, María Pía Ferraz, et al.. (2015). Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard. Blood Cells Molecules and Diseases. 54(4). 307–314. 57 indexed citations
16.
Ferraz, María Pía, André R. A. Marques, Paulo Gaspar, et al.. (2015). Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders. Molecular Genetics and Metabolism. 117(2). 186–193. 34 indexed citations
17.
Marques, André R. A., Jan Aten, Roelof Ottenhoff, et al.. (2015). Reducing GBA2 Activity Ameliorates Neuropathology in Niemann-Pick Type C Mice. PLoS ONE. 10(8). e0135889–e0135889. 51 indexed citations
18.
Dahl, Maria, Alexander Doyle, Karin Olsson, et al.. (2015). Lentiviral Gene Therapy Using Cellular Promoters Cures Type 1 Gaucher Disease in Mice. Molecular Therapy. 23(5). 835–844. 47 indexed citations
19.
Mirzaian, Mina, Gertjan Kramer, & Ben J. H. M. Poorthuis. (2015). Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography-tandem mass spectrometry. Journal of Lipid Research. 56(4). 936–943. 33 indexed citations
20.
Smid, Bouwien E., Saskia M. Rombach, Johannes M. F. G. Aerts, et al.. (2011). Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients. Orphanet Journal of Rare Diseases. 6(1). 69–69. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026